Patent Assignment
Reel/Frame 051422/0194
Assignment of Assignor's Interest
Recorded: 2020-01-06
Pages: 9
Assignors
MASUMOTO, SHUJI
Executed: 2019-12-13
TANAKA, HIROAKI
Executed: 2019-12-13
KUREBAYASHI, HIROTAKA
Executed: 2019-12-17
HASHIZUKA, TAKAHIKO
Executed: 2019-12-16
ARIKAWA, YUKA
Executed: 2019-12-12
Assignee
SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
6-8, DOSHO-MACHI 2-CHOME,, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
CDK9 Inhibitors and Polymorphs Thereof for Use as Agents for Treatment of Cancer
Patent:
11,034,710 →
Application:
16/703,773 →
Publication:
US 2020/0255462
PCT:
PCT/US2019/064549 ↗
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 6, 2020
From: SIDDIQUI-JAIN, ADAM; FLYNN, PAUL; FUJIWARA, YUJI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051421/0868 →
Assignment of Assignor's Interest
Jan 6, 2020
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051422/0287 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0833 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0705 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →